title: Neuroleptic malignant syndrome while on tiapride treatment.
authors.forename: J
authors.initials: J
authors.lastname: Duarte
authors.forename: J M
authors.initials: JM
authors.lastname: Campos
authors.forename: C
authors.initials: C
authors.lastname: Cabezas
authors.forename: V
authors.initials: V
authors.lastname: Sagredo
authors.forename: J
authors.initials: J
authors.lastname: Cortina
authors.forename: L E
authors.initials: LE
authors.lastname: Clavería
mesh_terms: D018726:Anti-Dyskinesia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D013976:Tiapamil Hydrochloride / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D018726:Anti-Dyskinesia Agents; D014150:Antipsychotic Agents; D013976:Tiapamil Hydrochloride